Literature DB >> 24493004

Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers.

Wonju Jo1, Dayeong Jeong, Junho Kim, Siwoo Cho, Su Chul Jang, Chungmin Han, Ji Yoon Kang, Yong Song Gho, Jaesung Park.   

Abstract

Exosomes/microvesicles are known to shuttle biological signals between cells, possibly by transferring biological signal components such as encapsulated RNAs and proteins, plasma membrane proteins, or both. Therefore exosomes are being considered for use as RNA and protein delivery vehicles for various therapeutic applications. However, living cells in nature secrete only a small number of exosomes, and procedures to collect them are complex; these complications impede their use in mass delivery of components to targeted cells. We propose a novel and efficient method that forces cells through hydrophilic microchannels to generate artificial nanovesicles. These mimetic nanovesicles contain mRNAs, intracellular proteins and plasma membrane proteins, and are shaped like cell-secreted exosomes. When recipient cells are exposed to nanovesicles from embryonic stem cells, mRNAs of Oct 3/4 and Nanog are transferred from embryonic stem cells to the target cells. This result suggests that mimetic nanovesicles can be used as vehicles to deliver RNA. This nanovesicle formation method is expected to be used in exosome research and to have applications in drug and RNA-delivery systems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24493004     DOI: 10.1039/c3lc50993a

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  31 in total

Review 1.  Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.

Authors:  Sarita Negi; Alissa K Rutman; Steven Paraskevas
Journal:  Curr Diab Rep       Date:  2019-07-31       Impact factor: 4.810

2.  Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations.

Authors:  Yi-Hsuan Ou; Shui Zou; Wei Jiang Goh; Jiong-Wei Wang; Matthias Wacker; Bertrand Czarny; Giorgia Pastorin
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics.

Authors:  Qingfu Zhu; Mikala Heon; Zheng Zhao; Mei He
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

Review 4.  Therapeutic applications of extracellular vesicles: clinical promise and open questions.

Authors:  Bence György; Michelle E Hung; Xandra O Breakefield; Joshua N Leonard
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

Review 5.  Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools.

Authors:  Song-Pei Li; Zhong-Xiao Lin; Xue-Yan Jiang; Xi-Yong Yu
Journal:  Acta Pharmacol Sin       Date:  2018-01-25       Impact factor: 6.150

Review 6.  Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.

Authors:  Mei He; Yong Zeng
Journal:  J Lab Autom       Date:  2016-05-23

7.  Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium.

Authors:  Yingjie Wang; Lan Zhang; Yongjun Li; Lijuan Chen; Xiaolong Wang; Wei Guo; Xue Zhang; Gangjian Qin; Sheng-hu He; Arthur Zimmerman; Yutao Liu; Il-man Kim; Neal L Weintraub; Yaoliang Tang
Journal:  Int J Cardiol       Date:  2015-05-08       Impact factor: 4.164

Review 8.  Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.

Authors:  Tianjiao Geng; Patrick Pan; Euphemia Leung; Qi Chen; Larry Chamley; Zimei Wu
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 9.  Exosomes as Reconfigurable Therapeutic Systems.

Authors:  R Steven Conlan; Simone Pisano; Marta I Oliveira; Mauro Ferrari; Inês Mendes Pinto
Journal:  Trends Mol Med       Date:  2017-07       Impact factor: 15.272

Review 10.  Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.

Authors:  J A Smith; T Leonardi; B Huang; N Iraci; B Vega; S Pluchino
Journal:  Biogerontology       Date:  2014-06-28       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.